FDA Approves Allergan's New-Sized Breast Implants
The FDA has approved Allergan Inc.'s request to market 2 new styles of its silicone breast implants for use in breast reconstruction, augmentation, and revision surgery.
The FDA has approved Allergan Inc.’s request to market 2 new styles of its silicone breast implants for use in breast reconstruction, augmentation, and revision surgery.
Now, patients will have more options for customizing Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants to match their body type, and the new X and L styles will also provide extra full projection, according to an Allergan press release. The implants are made of a highly cohesive silicone gel, and they aim to achieve 2 goals: holding their shape over time and remaining soft to the touch.
Prior to its approval of the new sizes, the FDA studied nearly 1000 women who used the previously approved range of Natrelle 410 breast implants, which are the most selected and extensively studied shaped gel implants, according to the release.
"Breast augmentation, revision, and reconstruction patients have varying needs when it comes to implants. Having additional implant options, such as the Natrelle 410 X and L styles, available to me and my patients enables me to provide the aesthetic outcomes they desire," said Patrick Maxwell, MD, a board certified plastic surgeon and founder of Maxwell Aesthetics in Nashville. "Based on my experience with the implants and a decade of safety data available, I feel confident recommending Natrelle 410 breast implants to my patients."